Read more IPO stories on Newserhttp://www.newser.com/taggrid/3933/ipo.html2009 - Newseren-usNewser Feed GeneratorTue, 24 Nov 2009 13:18:57 CSThttp://www.newser.com/story/66234/wall-street-rakes-in-1b-in-fees-on-aig-breakup.html?utm_source=syn&utm_medium=rss&utm_campaign=tagThe crumbling of AIG forced taxpayers to take on 80% of the company, but breaking the insurance giant up is turning out to be a bonanza for lawyers and banks. The Wall Street Journal calculates that firms will pull in $1 billion in fees from AIG and the Fed—one...http://www.newser.com/story/66234/wall-street-rakes-in-1b-in-fees-on-aig-breakup.html?utm_source=syn&utm_medium=rss&utm_campaign=tagThu, 06 Aug 2009 7:18:02 CDThttp://www.newser.com/story/60200/opentable-brings-false-hope-for-ipos.html?utm_source=syn&utm_medium=rss&utm_campaign=tagA hot website goes public, and investors go wild. Shares soar 59% on the first day of trading. “Is this really May 2009?” asks James B. Stewart of SmartMoney. The stock is OpenTable.com, which went public at $20 and is trading just south of $27. "The company seems to...http://www.newser.com/story/60200/opentable-brings-false-hope-for-ipos.html?utm_source=syn&utm_medium=rss&utm_campaign=tagWed, 27 May 2009 13:21:01 CDThttp://www.newser.com/story/59514/zuckerberg-facebook-ipo-a-few-years-out.html?utm_source=syn&utm_medium=rss&utm_campaign=tagMark Zuckerberg tells Reuters he does indeed intend to take Facebook public—just don't hold your breath waiting for it. The company is still "a few years out from that," said the 25-year-old co-founder. He said Facebook has plenty of capital, though he didn't deny that company execs have been...http://www.newser.com/story/59514/zuckerberg-facebook-ipo-a-few-years-out.html?utm_source=syn&utm_medium=rss&utm_campaign=tagTue, 19 May 2009 20:06:37 CDThttp://www.newser.com/story/56357/going-public-in-bear-market-is-risky-bet-for-rosetta-stone.html?utm_source=syn&utm_medium=rss&utm_campaign=tagRosetta Stone, the popular language-learning software maker, holds its initial public stock offering today—a risky move in a bear market, Jennifer Collins reports for Marketplace. Rosetta Stone’s profit has quadrupled since 2007, but it could make twice as much by waiting. It’s possible Rosetta needs cash now, which would...http://www.newser.com/story/56357/going-public-in-bear-market-is-risky-bet-for-rosetta-stone.html?utm_source=syn&utm_medium=rss&utm_campaign=tagThu, 16 Apr 2009 12:48:19 CDThttp://www.newser.com/story/56210/ebay-to-spin-off-skype-in-ipo-next-year.html?utm_source=syn&utm_medium=rss&utm_campaign=tagEbay plans to end its uneasy relationship with Skype by offloading the ill-fitting acquisition through an IPO early next year, Bloomberg reports. Analysts say the move could raise up to $1 billion for eBay, depending on how much equity the auction powerhouse wants to give up. The company declined to...http://www.newser.com/story/56210/ebay-to-spin-off-skype-in-ipo-next-year.html?utm_source=syn&utm_medium=rss&utm_campaign=tagWed, 15 Apr 2009 5:00:52 CDThttp://www.newser.com/story/51831/nasdaq-swipes-80b-in-nyse-listings.html?utm_source=syn&utm_medium=rss&utm_campaign=tagIn the war for stock listings, Nasdaq is on the offensive, offering companies beefed-up information and appearances on the exchange's towering Times Square video screen to woo them from the NYSE, the Wall Street Journal reports. Nasdaq was "very aggressive in creating marketing opportunities" for Dreamworks, including a 7-story Shrek...http://www.newser.com/story/51831/nasdaq-swipes-80b-in-nyse-listings.html?utm_source=syn&utm_medium=rss&utm_campaign=tagThu, 26 Feb 2009 8:35:00 CSThttp://www.newser.com/story/43322/ailing-biotech-firms-need-shot-in-the-arm.html?utm_source=syn&utm_medium=rss&utm_campaign=tagFor the first time in years, the biotech industry is in desperate need of a lifeline, Bloomberg reports, as the economic crisis threatens to shove companies into bankruptcy and derail the development of potentially life-saving drugs. “I’m looking down the barrel of a gun,” admitted one CEO. Five such companies...http://www.newser.com/story/43322/ailing-biotech-firms-need-shot-in-the-arm.html?utm_source=syn&utm_medium=rss&utm_campaign=tagFri, 21 Nov 2008 13:05:01 CSThttp://www.newser.com/story/37539/wall-street-woes-will-wallop-tech-sector.html?utm_source=syn&utm_medium=rss&utm_campaign=tagTroubles hitting the Wall Street giants promise particularly dark days ahead for the tech business world, analysts tell CNET News. The problems are bound to stifle mergers and acquisitions in the tech industry and further dampen the market for initial public offerings. IPOs have already slowed to a trickle—and...http://www.newser.com/story/37539/wall-street-woes-will-wallop-tech-sector.html?utm_source=syn&utm_medium=rss&utm_campaign=tagTue, 16 Sep 2008 2:02:47 CDThttp://www.newser.com/story/34278/insider-sales-put-facebooks-value-at-fraction-of-15b.html?utm_source=syn&utm_medium=rss&utm_campaign=tagThough the stake bought by Microsoft last fall pegged Facebook’s value at $15 billion, a rush of stock sales by insiders at the still-private company shows they think it’s worth much less, BusinessWeek reports. Even Mark Zuckerberg, founder and CEO of the social-networking giant, reportedly has sold some shares, and...http://www.newser.com/story/34278/insider-sales-put-facebooks-value-at-fraction-of-15b.html?utm_source=syn&utm_medium=rss&utm_campaign=tagWed, 06 Aug 2008 13:22:01 CDT